Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-14-035486
Filing Date
2014-11-04
Accepted
2014-11-04 19:42:33
Documents
1
Period of Report
2014-11-03

Document Format Files

Seq Description Document Type Size
1 rrd418295.html 4  
1 rrd418295.xml 4 2894
  Complete submission text file 0001181431-14-035486.txt   4419
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Issuer) CIK: 0001396814 (see all company filings)

EIN.: 510619477 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PACIRA PHARMACEUTICALS, INC. 5 SYLVAN WAY, SUITE 100 PARSIPPANY NJ 07054
Business Address
Kronenfeld Mark A. (Reporting) CIK: 0001578074 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35060 | Film No.: 141194686